Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
LIC MF Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.11.1918463906.9682
Domestic EquitiesZydus Lifesciences Ltd.6.9998457054.3582
Domestic EquitiesJB Chemicals & Pharmaceuticals Ltd.6.4427210544.0113
Domestic EquitiesPiramal Pharma Ltd.6.38402767003.9748
Domestic EquitiesCipla Ltd.6.0994271263.7976
Domestic EquitiesDivi's Laboratories Ltd.5.338183043.3236
Domestic EquitiesTorrent Pharmaceuticals Ltd.5.2633124013.2770
Domestic EquitiesDr. Reddy's Laboratories Ltd.5.087151053.1673
Domestic EquitiesGlenmark Pharmaceuticals Ltd.4.7386279072.9503
Domestic EquitiesIPCA Laboratories Ltd.4.6126214402.8719
Domestic EquitiesMankind Pharma Ltd.4.5829120682.8534
Domestic EquitiesArtemis Medicare Services Ltd.4.57521561722.8486
Domestic EquitiesAbbott India Ltd.4.358110262.7134
Domestic EquitiesApollo Hospitals Enterprise Ltd.4.308845112.6827
Domestic EquitiesGlobal Health Ltd.4.1867180372.6067
Domestic EquitiesAlkem Laboratories Ltd.3.748548292.3339
Domestic EquitiesMetropolis Healthcare Ltd.3.0136103221.8763
Domestic EquitiesLaurus Labs Ltd.2.2478311001.3995
Domestic EquitiesNeogen Chemicals Ltd.1.743570371.0855
Domestic EquitiesSyngene International Ltd.1.5205137370.9467
Total 96.4431 60.0469
Cash & Cash Equivalents and Net AssetsTreps4.1422 2.5790
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)-0.5853 -0.3644
Total 3.5569 2.2146
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Awareness & Information | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.